In our latest newsletter, we introduce you to our new Chief Medical Officer - J. Aaron Grantham, MD
            
Not rendering correctly? View this email as a web page here.
            
Main Header

Corindus

Key Takeaways from San Diego Cardiovascular Interventions 2016

J. Aaron Grantham, MD, Joins Corindus Vascular Robotics as Chief Medical Officer

We are pleased to announce that Aaron Grantham, MD, a leading interventional cardiologist, and an innovator in the treatment of chronic total occlusions (CTOs), has joined the company as Chief Medical Officer (CMO). Dr. Grantham will be spearheading Corindus' initiatives to educate the interventional cardiology community on the benefits of robotic therapy and will be leading efforts to develop clinical data to advance the CorPath® System’s applicability for additional clinical indications. As a practicing CMO, Dr. Grantham will continue treating patients at Saint Luke's Mid America Heart Institute.

Read More

spac5.gif
Corindus and ACIST Collaborate

Corindus and ACIST Collaborate to Improve PCI Workflow for Clinicians and Patients

We recently announced a collaboration with ACIST Medical Systems to provide workflow solutions with advanced technologies in the cath lab. "Both Corindus and ACIST share the strong vision of how physicians and their teams should operate in the cath lab,” said Mark Toland, Chief Executive Officer, Corindus Vascular Robotics. “This collaboration is the first step towards realizing this vision by providing innovative solutions to optimize workflow, improve safety, and eventually enhance patient care.”

Read More

spac5.gif
5 Technologies to Reduce Cath Lab Radiation Exposure

5 Technologies to Reduce Cath Lab Radiation Exposure

Diagnostic & Interventional Cardiology recently published an article highlighting 5 technologies available in the cath lab to reduce radiation exposure and the occupational hazards of working in the lab. Concern continues to grow for the serious risks interventionalists and their cath lab team’s face. New studies have shed light on potential risks including brain tumors, posterior subcapsular lens changes, and thyroid disease among others. Robotic therapy is among the new technologies that have the potential to both reduce radiation exposure and associated orthopedic strain from heavy lead protective apparel. In addition to these benefits, cardiovascular robotics has potential benefits for patients.

Read More

spac5.gif
TCT 2016
spac5

New eBook: Guide to Building a Vascular Robotic Program

Interested in starting a CorPath Vascular Robotic Program at your hospital?

Download our free eBook to learn more about building a successful program.

Download the eBook

Corindus

 
www.corindus.com

For more information on CorPath email: [email protected]

Copyright Corindus, Inc.
309 Waverley Oaks Road, Suite 105, Waltham, MA 02452, US
Corporate Office: 508-653-3335 | Sales & Customer Service: 800-605-9635 | Fax: 508-232-6000

 

www.corindus.com | Contact us